Liquid biopsy is one of the most exciting areas in diagnostics today. Performing a liquid biopsy means testing a sample of blood or saliva, looking for traces of cancerous DNA, which is evident in the blood before a tumour is visible on a scan.
The potential for liquid biopsy is, therefore, huge. In this video, our specialists in the diagnostics market Eleanor and Adam have taken a look at liquid biopsy, with the help of Business Development Consultant in Oncology and Liquid Biopsy, Dale Yuzuki.
If you found this video interesting and would like to speak to us about all things liquid biopsy, then get in touch!
You can reach us via email at Eleanor.Doolin@lifesci-cm.com or Adam.Hargreaves@lifesci-cm.com.
Get insight from Jonathon Romanowsky, co-founder of Inflammatix, and Stefan Willemsen, former President and CEO of the US subsidiary of bioMerieux and board member of Sepsis Alliance. Our latest video on Sepsis is available to watch now.
For similar content to this, you can find more of Eleanor's content on her consultant page and Adam's on his consultant page.
Lastly, our huge thanks go to Dale for his participation - you can follow him on LinkedIn here.
Featuring CEO & Co-Founder of FlexMedical Solutions, Kevin Fallon.
In this live webinar, I welcomed two esteemed guests with over 20 years combined experience in corporate development to break down strategies and processes and discuss their insights. Click to watch the full recording.
In this episode, we speak with Erez Naaman, Co-Founder & CTO at Scopio Labs, about what to introduction of AI means for the future of the diagnostics market.
Comments.